TSON Key Stats
- CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog Zacks May 22
- TRANS1 INC Files SEC form 10-Q, Quarterly Report May 15
- TRANS1 INC Files SEC form 8-K, Results of Operations and Financial Condition, Fi... May 10
- TranS1 Inc. Reports Operating Results for the First Quarter of 2013, Issues Seco... May 9
- TranS1 Earnings Preview: Get Ahead of the Analysts May 9
- Q1 2013 TRANS1 INC Earnings Release - After Market Close May 9
- TRANS1 INC Files SEC form 8-K, Entry into a Material Definitive Agreement Apr 30
- TranS1 Inc. Schedules First Quarter 2013 Results Conference Call for Thursday, M... Apr 26
- TRANS1 INC Files SEC form 8-K, Entry into a Material Definitive Agreement Apr 22
- Stocks Hitting 52-Week Lows Benzinga Apr 16
TSON Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). TranS1 is down 40.27% over the last year vs S&P 500 Total Return up 28.68%, Haemonetics Corporation up 16.63%, and Baeta down 36.67%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Pro Ratings for TSON
Pro Report PDF for TSON
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download TSON Pro Report PDF
Pro Strategies Featuring TSON
Did TranS1 make it into our Pro Portfolio Strategies?